Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.
about
Endocrine therapy for gynecological cancer.Is there a growing role for endocrine therapy in the treatment of breast cancer?Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer.Estrone sulphate, FSH, and testosterone levels in two male breast cancer patients treated with aromatase inhibitorsPlasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.Combined treatment with 4-hydroxyandrostenedione and aminoglutethimide: effects on aromatase inhibition and oestrogen suppression.The influence of CGS 16949A on peripheral aromatisation in breast cancer patients.Endocrine, pharmacokinetic and clinical studies of the aromatase inhibitor 3-ethyl-3-(4-pyridyl)piperidine-2,6-dione ('pyridoglutethimide') in postmenopausal breast cancer patients.Plasma estrone sulfate concentrations and genetic variation at the CYP19A1 locus in postmenopausal women with early breast cancer treated with letrozole.Aromatase inhibition 2013: clinical state of the art and questions that remain to be solvedNew endocrine drugs for treatment of advanced breast cancer.Clinical implications of estrone sulfate measurement in laboratory medicine.Aromatase inhibition for breast cancer treatment.
P2860
Q33843872-4DF157B6-3FCC-41CA-959A-3F0499B365CEQ33993658-86BDB866-5D68-4B1E-9D1E-06903468633DQ35349533-63268A0D-28C0-4461-A143-330B99805C00Q35583869-F930391F-4FFE-4CF9-B4C1-3565D5E659A1Q35977200-BC243E7D-360C-42EB-986C-850CFFACA578Q35979241-938F51D1-8884-4541-B22C-34A3A53FF4E7Q35984346-DDD13459-BFFE-4ED8-AC6C-22A58958E1D2Q35993244-ECB9BBC2-3EF1-4CDB-85E8-20E627F2305AQ36484937-7C7F43AB-D581-4534-B440-2C21C5D174B9Q36946008-FCA8F297-8551-4748-A3F3-61378526B6F9Q37938324-1D265EE7-890B-40CE-8B00-34549AFFE317Q39037694-E61694E2-28B2-4939-9FC3-1BE799078D63Q41463872-E0928F8C-8CCA-4846-B8E8-1AAFA7771BE4
P2860
Alterations in the production rate and the metabolism of oestrone and oestrone sulphate in breast cancer patients treated with aminoglutethimide.
description
1989 nî lūn-bûn
@nan
1989年の論文
@ja
1989年学术文章
@wuu
1989年学术文章
@zh-cn
1989年学术文章
@zh-hans
1989年学术文章
@zh-my
1989年学术文章
@zh-sg
1989年學術文章
@yue
1989年學術文章
@zh
1989年學術文章
@zh-hant
name
Alterations in the production ...... reated with aminoglutethimide.
@ast
Alterations in the production ...... reated with aminoglutethimide.
@en
type
label
Alterations in the production ...... reated with aminoglutethimide.
@ast
Alterations in the production ...... reated with aminoglutethimide.
@en
prefLabel
Alterations in the production ...... reated with aminoglutethimide.
@ast
Alterations in the production ...... reated with aminoglutethimide.
@en
P2860
P356
P1476
Alterations in the production ...... reated with aminoglutethimide.
@en
P2093
Johannessen DC
P2860
P2888
P304
P356
10.1038/BJC.1989.231
P407
P577
1989-07-01T00:00:00Z